In:
Current Oncology, MDPI AG, Vol. 28, No. 6 ( 2021-11-15), p. 4738-4747
Abstract:
Background: To determine the correlation between urine loss in PAD-test after catheter removal, and early urinary continence (UC) in RP treated patients. Methods: Urine loss was measured by using a standardized, validated PAD-test within 24 h after removal of the transurethral catheter, and was grouped as a loss of 〈 1, 1–10, 11–50, and 〉 50 g of urine, respectively. Early UC (median: 3 months) was defined as the usage of no or one safety-pad. Uni- and multivariable logistic regression models tested the correlation between PAD-test results and early UC. Covariates consisted of age, BMI, nerve-sparing approach, prostate volume, and extraprostatic extension of tumor. Results: From 01/2018 to 03/2021, 100 patients undergoing RP with data available for a PAD-test and early UC were retrospectively identified. Ultimately, 24%, 47%, 15%, and 14% of patients had a loss of urine 〈 1 g, 1–10 g, 11–50 g, and 〉 50 g in PAD-test, respectively. Additionally, 59% of patients reported to be continent. In multivariable logistic regression models, urine loss in PAD-test predicted early UC (OR: 0.21 vs. 0.09 vs. 0.03; for urine loss 1–10 g vs. 11–50 g vs. 〉 50 g, Ref: 〈 1 g; all p 〈 0.05). Conclusions: Urine loss after catheter removal strongly correlated with early continence as well as a severity in urinary incontinence.
Type of Medium:
Online Resource
ISSN:
1718-7729
DOI:
10.3390/curroncol28060399
Language:
English
Publisher:
MDPI AG
Publication Date:
2021
detail.hit.zdb_id:
2270777-3
Permalink